David Einhorn acquired 1.27 Million Coya Therapeutics shares worth $11.1 Million. That's 0.50% of their equity portfolio (25th largest holding). The investor owns 16.02% of the outstanding Coya Therapeutics stock. The stake costed the investor $6.6 Million, netting the investor a gain of 69% so far.